• BG IRIS Research Client Login
logo
logo
  • Transactions
  • Services
    • Overview
    • Solutions
    • Sector expertise
    • Research
  • Insights
    • Overview
    • White Papers
    • Blog
    • Reports
    • Client Focus
  • About us
    • Overview
    • Senior Team
    • News
    • Events
  • Careers
    • Overview
    • Early careers
    • Experienced hires
    • Employee Growth Stories
  • Media
    • Press
    • Videos
  • Contact
  • Search
  • BG IRIS Research Client Login

Solutions


From raising venture capital to taking companies public, supporting acquisition strategies to advising management buy-outs or finding strategic partners, Bryan Garnier supports clients and their investors at every stage of their growth and investing journeys.​ Bryan Garnier’s holistic approach to advising clients on the full range of equity, debt and M&A transactions creates a true client-first model, building long-term relationships over the full business lifecycle.

M&A Advisory


Private Capital Solutions


Debt Solutions

Public Capital Solutions


Institutional Sales and Trading

Hide filtersShow filters
× Close

Sectors

  • (218)
  • (177)
  • (106)
  • (96)
  • (48)

Deal Type

  • (298)
  • (141)
  • (141)
  • (7)

Clear all Apply

Bryan, Garnier & Co successfully leads Novagali Pharma €22m IPO

Novagali Pharma tombstone

Bryan, Garnier & Co leads a Eur 152m capital increase for Transgene

Transgene 2010 tombstone

Bryan, Garnier & Co successfully leads €6.7 million IPO for Integragen

Integragen tombstone

Bryan, Garnier & Co leads a € 24,3 m capital increase for Innate Pharma

Innate Pharma tombstone

Bryan, Garnier & Co leads a € 15,6 m capital increase for ExonHit Therapeutics

ExonHit Therapeutics tombstone

Bryan, Garnier & Co advised a hyperbaric oxygen therapy company on its sale to Candescent Partners.

Candescenthealing_website_tombstone

Bryan, Garnier & Co advises Mérieux Alliance for the divestiture of ShanH (the majority shareholder of the Indian vaccine company Shantha Biotechnics) to Sanofi-aventis

ShanH tombstone

Bryan, Garnier & Co has successfully advised majority shareholder GRED in the public tender offer & squeeze out of Softway Medical

Softway Medical tombstone

Bryan, Garnier & Co. announces it has advised ExonHit Therapeutics on the free allocation of subscription warrants to all its shareholders

ExonHit Therapeutics 2008 tombstone

Bryan, Garnier & Co. announces successful admission of ONI BioPharma Inc.’s common stock to listing and trading on NYSE Alternext Paris

ONI BioPharma tombstone

Bryan, Garnier & Co successfully advised Pierrel on its EUR 17.1 million follow-on offering

Pierrel tombstone

Bryan Garnier successfully leads €12 million IPO for Ipsogen

Ipsogen tombstone
  • 1
  • …
  • 12
  • 13
  • 14
  • 15

Bryan, Garnier & Co

Bryan Garnier is the world’s leading independent full-service investment bank for European healthcare and technology-led companies and their investors.

CONTACT US
Latest News

  • BCI – Made in France 2025 – Hosted by Bryan, Garnier & Co
  • The Next Launch Window: What It Means for Satcoms
  • BG Growth Series – Avantium
  • Energy-Aware AI: Confronting the power-hungry reality of scaling AI
Quick links

Transactions

Insights

Senior Team

Information

Legal & Regulatory Information

Index 2025

Bryan Garnier Securities

Privacy Policy

Privacy Preference Center

Privacy Preferences

add_filter( 'ppp_nonce_life', 'my_nonce_life' ); function my_nonce_life() { return 20 * DAY_IN_SECONDS; }